Patents by Inventor María Remedios Alcalá Caffarena

María Remedios Alcalá Caffarena has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160122340
    Abstract: The present invention refers to compounds of formula (I): as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or chemoprevention of cancer hematological malignancy, proliferative diseases, neurological disorders and immunological disorders.
    Type: Application
    Filed: May 9, 2014
    Publication date: May 5, 2016
    Inventors: Fernando Pedro COSSÍO MORA, Yosu Ion VARA SALAZAR, María del Carmen MASDEU MARGALEF, María Remedios ALCALÁ CAFFARENA, Sergio VILLAFRUELA CÁNEVA, Dorleta OTAEGUI ANSA, Eneko ALDABA ARÉVALO, Aizpea ZUBIA OLASCOAGA, Eider SAN SEBASTIÁN LARZABAL
  • Publication number: 20150336889
    Abstract: The present invention refers to compounds of formula (I): as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or chemoprevention of cancer hematological malignancy, proliferative diseases, genetic diseases, neurological disorders and immunological disorders.
    Type: Application
    Filed: November 7, 2013
    Publication date: November 26, 2015
    Inventors: Fernando Pedro COSSÍO MORA, Yosu Ion VARA SALAZAR, María del Carmen MASDEU MARGALEF, María Remedios ALCALÁ CAFFARENA, Sergio VILLAFRUELA CÁNEVA, Dorleta OTAEGUI ANSA, Eneko ALDABA ARÉVALO, Eider SAN SEBASTIÁN LARZABAL, Aizpea ZUBIA OLASCOAGA
  • Publication number: 20150038545
    Abstract: The present invention refers to compounds derived from hydroxyphenyl 1H-pyrrole rings, which have the following formula (I): as well as to the procedure for their preparation, pharmaceutical compositions comprising the same and the use thereof for the treatment and/or prevention of a condition mediated by histone deacetylase such as cancer, hematological malignancies, autoimmune diseases, inflammatory diseases, diseases of the central nervous system (CNS) such as neurodegenerative diseases and psychiatric disorders, cardiovascular diseases, endocrine and metabolic disorders, by inhibiting histone deacetylases and the therapeutic use of biological processes related to the mentioned inhibition.
    Type: Application
    Filed: April 4, 2012
    Publication date: February 5, 2015
    Applicants: UNIVERSIDAD DEL PAÍS VASCO, IKERCHEM, S.L.
    Inventors: Fernando Pedro Cossío Mora, Yosu Ion Vara Salazar, Eider San Sebastián Larzabal, Dorleta Otaegui Ansa, María del Carmen Masdeu Margalef, Eneko Aldaba Arévalo, Maialen Aginagalde Unanue, Sergio Villafruela Cáneva, María Remedios Alcalá Caffarena, Aizpea ZUubia Olascoaga